Therefore, we aimed to us a simple pharmacological approach to test if PDH could indeed be crucial for pluripotency, and if some of the metabolic regulatory pathways, found in cancer cells are also present in ESCs, which could constitute a link between cancer proliferation and stem cell pluripotency. The gene discussed is PDP1; the disease is cancer.